FDA Investigator Joan M Cantellops Figueroa

Joan M Cantellops Figueroa has inspections in 7 countries as of 15 Sep 2023. Joan M Cantellops Figueroa has collaborated with a combinined 1554 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
16
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India, United States of America, Denmark, Mexico, Croatia, United Kingdom of Great Britain and Northern Ireland, Sweden
Co-Investigator(s):
Alan A Rivera, Alan L Truong, An T Vu, Angelica M Hernandez, Arlene M Badillo, Azza Talaat, Barbara J Rincon, Brian D Nicholson, Carla A Norris, Cheryl A Clausen, Concepcion Cruz, Jr, Dayna I Martinez, Edmund F Mrak, Jr, Eric L Dong, BS, Felix Maldonado, Frances L Dejesus, Gam S Zamil, Garcial, Helen Verdel, Heriberto Negron Rivera, Iraida Ortiz, Ivis Lnegron Torres, Ivonne A Vicente, Javier O Vega, Joan Cantellops, Joan Cantellops Figueroa, Jolanna A Norton, Jorge L Guadalupe, Jorge L Lajara, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Melendez, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Kellia N Hicks, Kevin A Gonzalez, Laurimer Kuilan, Laurimer Kuilan Torres, Leslie A Mendoza, Libia M Lugo, Liming Zhang, Linda F Murphy, Lisa M Lopez, Loreily Figueroa, Loreily Figueroa Agrinsoni, LT Luis O Rodriguez, Margarita Santiago, Maria Estrella, Marian E Ramirez, Marianela Aponte Cruz, Marisal Faberhe, Marisol Faberlle, Marvin D Jones, Michael L Casner, Michele L Forster, PhD, Miguel A Martinez, Mihaly S Ligmond, Milva E Melendez, Mra Mcculloughj, Mra Munizn, Mra Narulaa, Myriam M Sosa, Nancy Rosado, Nicole E Knowlton, Noreen Muniz, Pankaj H Amin, Patrick C Klotzbuecher, Peter E Baker, Rajiv R Srivastava, Ramon A Hernandez, Randa Melhem, PhD, Raquel Gonzalez, Raquel Gonzalez Rivera, Rebecca Parrilla, Sangeeta M Khurana, PhD, Satheesh K Podaralla, Sonia M Monges, Steven D Kehoe, Steven P Donald, Truong Xuan Nguyen (Andy), Vilmary Negron Rodriguez, Vioela J Caze, Viviana Matta, William A Warnick

Joan M Cantellops Figueroa's Documents

Publish Date Document Type Title
March, 2023 FDA 483 SHILPA MEDICARE LIMITED - Form 483, 2023-03-10
March, 2023 FDA 483 InterMed Laboratories Private Limited - Form 483, 2023-03-17
June, 2016 FDA 483 Pharma-Bio Serv, Inc - Form 483, 2016-07-01
October, 2016 FDA 483 Auro PR Inc. - Form 483, 2016-10-24

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more